Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of Analogues.

Cleghorn, Laura AT; Wall, Richard J; Albrecht, Sébastien; MacGowan, Stuart A; Norval, Suzanne; De Rycker, Manu; Woodland, Andrew; Spinks, Daniel; Thompson, Stephen; Patterson, Stephen; +12 more... Corpas Lopez, Victoriano; Dey, Gourav; Collie, Iain T; Hallyburton, Irene; Kime, Robert; Simeons, Frederick RC; Stojanovski, Laste; Frearson, Julie A; Wyatt, Paul G; Read, Kevin D; Gilbert, Ian H; Wyllie, Susan; (2023) Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of Analogues. Journal of medicinal chemistry, 66 (13). pp. 8896-8916. ISSN 0022-2623 DOI: https://doi.org/10.1021/acs.jmedchem.3c00509

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1021/acs.jmedchem.3c00509

Abstract

Share

Download

Filename: Cleghorn-etal-2023-Development-of-a-2-4-Diaminothiazole-Series.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar